Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

Por de Jong, P H, Hazes, J M, Han, H K, Huisman, M, van Zeben, D, van der Lubbe, P A, Gerards, A H, van Schaeybroeck, B, de Sonnaville, P B, van Krugten, M V, Luime, J J, Weel, A E
Publicado em 2014